Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer

Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer

Aim: to perform a comparative analysis of epithelial ovarian cancer (ОС) recurrence rate in patients with/without long-term anticoagulant therapy (АСТ) as a part of secondary prevention of thrombotic complications.Materials and Methods. A prospective interventional non-randomized comparative study w...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Vorobev, V. O. Bitsadze, J. Kh. Khizroeva, A. G. Solopova, D. M. Mamchich, E. D. Mun, D. V. Blinov, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2025-07-01
Series:	Акушерство, гинекология и репродукция
Subjects:	anticoagulant therapy аст ovarian cancer oc relapse metastasis venous thromboembolism direct oral anticoagulants thrombin fibrin matrix thrombosis tumor invasion antitumor effect
Online Access:	https://www.gynecology.su/jour/article/view/2493
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01)

Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis
by: A. V. Vorobеv, et al.
Published: (2025-05-01)

Application of thrombin powder after tooth extraction in patients receiving anticoagulant therapy
by: Marjanović Marjan
Published: (2002-01-01)

Dependence of clot structure and fibrinolysis on apixaban and clotting activator
by: Rebecca A. Risman, et al.
Published: (2024-11-01)

APTAMERS ARE NEW PHARMACOLOGICAL SUBSTANCES FOR THE DEVELOPMENT OF ANTICOAGULANTS
by: A. V. Mazurov, et al.
Published: (2017-05-01)

Thrombin generation to evaluate the complex hemostatic balance of hemophilia A plasma containing direct oral anticoagulant and supplemented by factor VIII
by: Sylvain Lamoine, et al.
Published: (2024-10-01)

Coagulation status in patients with pulmonary embolism receiving long-term anticoagulant therapy
by: E. A. Shmidt, et al.
Published: (2022-01-01)

Thrombophilia identified as a risk factor for thrombogenesis in cancer patients
by: A. V. Vorobev, et al.
Published: (2021-07-01)

Long-term anticoagulant therapy in the aspect of secondary prevention of recurrent pulmonary embolism
by: E. A. Shmidt, et al.
Published: (2024-06-01)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis
by: Anne Godier, et al.
Published: (2025-03-01)

Protofibril packing density of individual fibers alters fibrinolysis
by: Rebecca A. Risman, et al.
Published: (2025-02-01)

Antithrombotic therapy in COVID-19 patients
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients
by: A. B. Sumarokov, et al.
Published: (2020-03-01)

Resolution of the International meeting of experts on the exchange of scientific experience in the use of anticoagulants in patients with COVID-19
by: S. N. Avdeev, et al.
Published: (2020-09-01)

Use of a direct thrombin inhibitor for intraoperative anticoagulation during endovascular abdominal aortic aneurysm repair in a patient with heparin-induced thrombocytopenia
by: A. E. Komlev, et al.
Published: (2021-06-01)

Disseminated intravascular coagulation in perinatal medicine
by: M. A. Mingalimov, et al.
Published: (2020-04-01)

HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
by: A. D. Makatsariya, et al.
Published: (2025-03-01)

From molecular medicine to artificial intelligence: prospects for reproductive medicine development
by: A. D. Makatsariya, et al.
Published: (2025-07-01)

Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome
by: A. D. Makatsariya, et al.
Published: (2020-07-01)

Chacma baboon natural anticoagulants and factor VIII activities
by: Quintin Andre van Staden, et al.
Published: (2025-04-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

The best practices of the Russian Federation in the organization of anticoagulant therapy in patients with high risk of thromboembolic events
by: T. V. Vavilova, et al.
Published: (2020-07-01)

An unusual complication during anticoagulant therapy
by: M. T. Vatutin, et al.
Published: (2015-10-01)

Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis
by: A. D. Makatsariya, et al.
Published: (2024-07-01)

The effect of oral anticoagulant use before visit for patients with COVID-19 on mortality: A meta-analysis
by: Cornelia Ghea, et al.
Published: (2023-01-01)

Liver function after transplantation in the assessment of the coagulation system and the concept of antithrombotic therapy
by: Marceli Lukaszewski, et al.
Published: (2020-03-01)

Corrigendum to «Innovative approaches to assessing risk factors, diagnostics and treatment of neonatal thrombosis» (https://doi.org/10.17749/2313-7347/ob.gyn.rep.2024.530)
by: A. D. Makatsariya, et al.
Published: (2024-11-01)

Anticoagulant therapy in patients with cardioembolic subtype of ischemic stroke and atrial fibrillation
by: E. A. Naryshkina, et al.
Published: (2025-06-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants
by: M. G. Chashchin, et al.
Published: (2023-11-01)

Should anti-vitamin K be started on the first day in non-high risk pulmonary embolism?
by: Koraćević Goran, et al.
Published: (2020-01-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

THROMBOSIS OF UNUSUAL SITES AND THROMBOPHILIA
by: S. V. Akinshina, et al.
Published: (2016-06-01)

State and adequacy of anticoagulant therapy in fibrillation of precurities in clinical practice
by: A. A. Tuchkov, et al.
Published: (2021-06-01)

Characterizing anticoagulation reversal practices in Colombia: Initial insights from a national registry
by: Sebastián Seni-Molina, et al.
Published: (2025-09-01)

Possible Factor Xa Resistance in a Patient Who Failed Apixaban and Rivaroxaban
by: Ola Ali, et al.
Published: (2024-12-01)

Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice
by: I. V. Zotova, et al.
Published: (2020-09-01)